Inve India ▾
OSOSELDEVICE

OSEL Devices Q4 FY25 results (Jan–Mar 2025) and concall

Healthcare · Concall AI · Call held 27 May 2025

OSEL Devices reported a strong FY25 with an 18% consolidated EBITDA margin and an estimated H2 revenue of ₹99 crores. The company announced a significant strategic move by securing an exclusive license for Philips mobile phones and tablets in India, projecting 15-20% EBITDA margins from this new segment. OSEL is targeting a 25% CAGR for its existing healthcare LED and LED display businesses, alongside plans for international expansion and entry into the retail segment for hearing aids, despite an increase in receivable days.

You’re reading a preview. Opening the full call uses 1 concall credit.

Sign in to use your monthly call allowance.

What they filed

₹ Cr · quarterly
Line itemQ2 FY24Q4 FY24Q2 FY25Q4 FY25
Revenue51 82 87 99
EBITDA9 14 13 20
Net profit5 8 8 12
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.